{
    "2018-07-01": [
        [
            {
                "time": "",
                "original_text": "进入中报预告期，关注Q2业绩确定性｜【光大医药·周报】",
                "features": {
                    "keywords": [
                        "中报预告",
                        "Q2业绩",
                        "确定性",
                        "光大医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "海外机构6月份调研52家公司 7只潜力股投资评级获提升",
                "features": {
                    "keywords": [
                        "海外机构",
                        "调研",
                        "潜力股",
                        "投资评级",
                        "提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2018 年半年报业绩前瞻【周观点|长江医药0701】",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2018",
                        "半年报",
                        "业绩前瞻",
                        "长江医药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "半年度盘点：次新股表现抢眼 74只浙股今年逆势上涨",
                "features": {
                    "keywords": [
                        "半年度",
                        "次新股",
                        "表现抢眼",
                        "浙股",
                        "逆势上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}